Journal of Dual Diagnosis,
Год журнала:
2025,
Номер
unknown, С. 1 - 12
Опубликована: Март 14, 2025
Objective:
Co-occurrence
of
schizophrenia/schizoaffective
disorder
(SSD)
and
stimulant
use
(StUD)
is
an
ongoing
clinical
problem
can
lead
to
poor
outcomes.
Although
emerging
evidence
has
suggested
psychostimulant
substitution
therapy
may
result
in
improved
outcomes
those
with
StUD,
the
efficacy
safety
for
StUD
concurrent
SSD
uncertain.
This
review
aims
systematically
find
assess
all
available
on
prescription
psychostimulants
co-occurring
StUD.
Methods:
Electronic
searches
MEDLINE,
PsycINFO,
Embase,
Scopus,
ClinicalTrials,
EU
Clinical
Trials,
CADTH
were
conducted
from
inception
February
27,
2024.
Any
study
design
was
accepted
if
they
involved
following
concepts
1)
2)
psychostimulants.
Given
paucity
trials
meeting
criteria,
interest
described
qualitatively.
Risk
bias
assessed
using
Q-Coh
ROB2.
Results:
Only
seven
articles
met
most
these
case
reports
series.
The
single
RCT
included
at
high
risk
bias.
Outcomes
abstinence,
reductions
non-prescribed
use,
psychiatric
hospitalizations,
levels
craving,
improvements
mental
health,
psychosocial
functioning,
adherence
antipsychotic
medications,
retention
treatment.
Most
results
indicated
that
individuals
SSD-StUD
not
associated
Conclusion:
Available
treatment
via
lacking.
More
exploration
required
this
question
allow
current
practice
be
backed
by
evidence.
Psychoactives,
Год журнала:
2025,
Номер
4(1), С. 2 - 2
Опубликована: Янв. 17, 2025
Background:
To
estimate
the
prevalence
of
co-occurring
obsessive–compulsive
disorder
(OCD)
with
substance
use
(SUD)
in
general
population.
Methods:
A
comprehensive
literature
search
was
conducted
on
comorbid
OCD
and
SUD
population
using
MEDLINE,
PsycINFO,
EMBASE
CINAHL.
Using
keywords,
relevant
studies
published
between
1993
2021
were
identified.
These
analysed
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analysis
(PRISMA)
guidelines
Meta-analysis
Observational
Studies
Epidemiology.
Results:
Fourteen
met
inclusion
criteria
had
a
total
combined
sample
size
47,850
participants.
The
lifetime
any
identified
patients
ranged
4.3%
62.4%.
Among
AUD,
14.1%
35.9%;
cannabis
OCD,
11.5%
24.4%;
tobacco
15%
23.1%.
Alcohol
commonest
psychoactive
used
most
reviewed
highest
males.
Conclusions:
In
conclusion,
this
review
highlights
variable
SUDs
individuals
emphasizing
that
association
differs
based
type
substance.
Overall,
rate
underscores
need
further
research
relationship
these
conditions
development
effective
treatment
strategies
address
both
disorders
concurrently.
Addiction Neuroscience,
Год журнала:
2024,
Номер
11, С. 100151 - 100151
Опубликована: Фев. 15, 2024
While
the
majority
of
people
with
cocaine
use
disorders
(CUD)
also
co-use
tobacco/nicotine,
most
preclinical
research
does
not
include
nicotine.
The
present
study
examined
nicotine
and
under
several
conditions
intravenous
drug
self-administration
in
monkeys,
as
well
potential
peripheral
biomarkers
associated
co-use.
In
Experiment
1,
male
rhesus
monkeys
(N=3)
self-administered
(0.001-0.1
mg/kg/injection)
alone
(0.01-0.03
a
progressive-ratio
schedule
reinforcement.
When
was
added
to
cocaine,
there
significant
leftward/upward
shift
number
injections
received.
2,
socially
housed
female
cynomolgus
(N=14)
concurrent
drug-vs-food
choice
Adding
solution
shifted
dose-response
curves
left,
more
robust
shifts
noted
animals.
There
no
evidence
social
rank
differences.
To
assess
reinforcing
strength,
delays
were
presentation
drug;
required
significantly
longer
decrease
choice,
compared
alone.
Blood
samples
obtained
post-session
used
analyze
concentrations
neuronally
derived
small
extracellular
vesicles
(NDE);
differences
NDE
profile
observed
for
kappa-opioid
receptors
when
co-used
each
controls.
These
results
suggest
that
interactions
involving
are
simply
changing
potency,
but
rather
resulting
changes
strength
should
be
utilized
better
understand
neuropharmacology
CUD
evaluation
treatments.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(7), С. 2154 - 2154
Опубликована: Апрель 8, 2024
In
1990,
the
United
States'
Institute
of
Medicine
promoted
principles
outcomes
monitoring
in
alcohol
and
other
drugs
treatment
field
to
improve
evidence
synthesis
quality
research.
While
various
national
outcome
measures
have
been
developed
employed,
no
global
consensus
on
standard
measurement
has
agreed
for
addiction.
It
is
thus
timely
build
an
international
consensus.
Convened
by
International
Consortium
Health
Outcomes
Measurement
(ICHOM),
international,
multi-disciplinary
working
group
reviewed
existing
literature
reached
a
globally
applicable
minimum
set
people
who
seek
Brain Sciences,
Год журнала:
2024,
Номер
14(6), С. 534 - 534
Опубликована: Май 24, 2024
The
global
issue
of
substance
abuse
demands
ongoing
initiatives
aligned
with
the
United
Nations
Sustainable
Development
Goals.
With
drug
use
remaining
prevalent
worldwide,
interventions
are
critical
to
addressing
associated
health
challenges
and
societal
implications.
Exercise
physical
activities
have
emerged
as
integral
components
disorder
(SUD)
treatment,
offering
promising
avenues
for
prevention,
intervention,
recovery.
Recent
research
underscores
efficacy
exercise
in
reducing
cravings,
promoting
abstinence,
improving
overall
well-being.
However,
integrating
into
SUD
recovery
programs
presents
such
dropout
rates
cultural
considerations.
This
paper
synthesizes
existing
literature
on
integration
recovery,
highlighting
strategies
enhancing
treatment
outcomes
barriers
adherence.
Drawing
cognitive–behavioral
therapy,
experiential
learning,
motivational
interviewing,
goal-setting
techniques,
holistic
approach
outlined
this
aims
empower
individuals
both
mentally
physically,
fostering
resilience
supporting
long-term
In
conclusion,
new
need
be
taken
by
advocating
inclusive
policies,
community
engagement,
collaborations
across
sectors.
By
doing
so,
stakeholders
can
optimize
effectiveness
contribute
sustainable
rehabilitation
efforts
SUD.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(2), С. 444 - 444
Опубликована: Янв. 7, 2025
Fentanyl
is
a
synthetic
opioid
widely
used
for
its
potent
analgesic
effects
in
chronic
pain
management
and
intraoperative
anesthesia.
However,
high
potency,
low
cost,
accessibility
have
also
made
it
significant
drug
of
abuse,
contributing
to
the
global
epidemic.
This
review
aims
provide
an
in-depth
analysis
fentanyl's
medical
applications,
pharmacokinetics,
metabolism,
pharmacogenetics
while
examining
adverse
forensic
implications.
Special
attention
given
misuse,
polydrug
interactions,
challenges
determining
cause
death
fentanyl-related
fatalities.
misuse
has
escalated
dramatically,
driven
by
substitution
heroin
availability
through
online
platforms,
including
dark
web.
Polydrug
use,
where
fentanyl
combined
with
substances
like
xylazine,
alcohol,
benzodiazepines,
or
cocaine,
exacerbates
toxicity
increases
risk
fatal
outcomes.
undergoes
rapid
distribution,
metabolism
CYP3A4
into
inactive
metabolites,
renal
excretion.
Genetic
polymorphisms
CYP3A4,
OPRM1,
ABCB1
significantly
influence
individual
responses
fentanyl,
affecting
efficacy
potential
toxicity.
Fentanyl's
side
include
respiratory
depression,
cardiac
arrhythmias,
gastrointestinal
dysfunction,
neurocognitive
impairments.
Chronic
disrupts
brain
function,
contributes
mental
health
disorders,
poses
risks
younger
older
populations
alike.
Fentanyl-related
deaths
require
comprehensive
investigations,
judicial
inspections,
autopsies,
toxicological
analyses.
Additionally,
co-administration
xylazine
presents
distinct
scientific
community.
Histological
immunohistochemical
studies
are
essential
understanding
organ-specific
damage,
pharmacogenetic
testing
can
identify
susceptibilities.
The
growing
prevalence
abuse
highlights
need
robust
protocols,
advanced
research
variability,
strategies
mitigate
misuse.
International
collaboration,
public
education,
harm
reduction
measures
critical
addressing
crisis
effectively.
Diagnostics,
Год журнала:
2025,
Номер
15(3), С. 239 - 239
Опубликована: Янв. 21, 2025
Mental
disorders
(MDs)
are
among
the
major
causes
of
morbidity
and
mortality
worldwide.
Individuals
with
severe
MDs
have
a
shorter
life
expectancy,
primarily
due
to
cardiovascular
diseases.
Echocardiography
facilitates
evaluation
alterations
in
cardiac
morphology
function,
resulting
from
various
pathologies.
The
aim
this
review
was
explore
current
evidence
base
behind
myocardial
deformation
observed
echocardiography
patients
MDs.
We
focused
on
data
regarding
speckle
tracking
echocardiography.
PubMed,
using
medical
subject
headings,
searched
identify
studies
topic.
collected
demonstrated
changes
function
schizophrenia,
bipolar
disorder,
depression,
anxiety
stressor-related
post-traumatic
stress
eating
disorders,
sleep–wake
substance-related
addictive
neurocognitive
borderline
personality
disorder.
recurrent
findings
included
impaired
Left
Ventricular
Ejection
Fraction
Hypertrophy.
Global
Longitudinal
Strain
significantly
altered
anorexia
nervosa,
disorders.
All
reported
support
consideration
cardiology
consultations
multidisciplinary
approach
care
suspected
dysfunction.
Further
investigation
is
warranted
determine
significance
prognostic
value
strain
measurements
individuals
MDs,
focusing
early
detection,
especially
asymptomatic
cases.
Pharmacy,
Год журнала:
2025,
Номер
13(1), С. 7 - 7
Опубликована: Янв. 22, 2025
The
complexities
surrounding
the
use
of
medications,
substance
abuse,
and
recreational
plants
are
multifaceted
warrant
a
comprehensive
examination.
This
review
highlights
consumption
chemical
substances
in
excess
or
for
non-medical
purposes,
obtained
through
legal
prescriptions,
over-the-counter
purchases,
illicit
means,
with
an
emphasis
on
predictive
role
stressors
individual-level
variables
development
disorders,
as
well
influence
regulatory
environment
patterns
consumption.
Additionally,
alarming
escalation
mortality
rate
associated
drug
opioid
overdoses
is
also
underscored.
prescription
medications
can
lead
to
significant
health
risks,
particularly
when
combined
other
substances;
therefore,
need
interventions
preventive
measures
address
abuse
among
various
populations
imperative.
Furthermore,
novel
insights
addiction,
exploring
neurobiological
mechanisms
underlying
discussing
treatment
approaches
elucidated.
Advancements
technology
detecting
highlighted,
displaying
innovative
tools
more
effective
identification
monitoring.
In
conclusion,
reveal
landscape
marked
by
overlapping
motivations
implications.
distinction
between
medical
critical
understanding
user
behavior
addressing
public
concerns.